|
|
|
Insider
Information: |
Sigal Elliot |
Relationship: |
Director |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
148,221 |
|
Indirect Shares
|
78,638 |
|
|
Direct
Value |
$5,965,895 |
|
|
Indirect Value
|
$5,479,085 |
|
|
Total
Shares |
226,859 |
|
|
Total
Value |
$11,444,981 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
EVP, CSO & President R... |
2013-06-03 |
148,221 |
2013-06-03 |
47,079 |
Premium* |
|
Mead Johnson Nutrition Co |
MJN |
Director |
2017-06-15 |
0 |
2017-06-15 |
0 |
Premium* |
|
Spark Therapeutics, Inc. |
ONCE |
Director |
2019-12-17 |
0 |
2015-02-04 |
31,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
133 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,796) |
207,107 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,062 |
212,462 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
441 |
212,903 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,452 |
214,559 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,875 |
217,979 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,714 |
217,616 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,173 |
220,789 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,062 |
227,439 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,866 |
231,305 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
46,365 |
270,287 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,453 |
256,249 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
85,830 |
338,624 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-09-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(250,788) |
298,840 |
0 |
- |
|
MJN |
Mead Johnson Nutrition Co |
Director |
|
2012-09-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,950) |
16,809 |
0 |
- |
|
MJN |
Mead Johnson Nutrition Co |
Director |
|
2012-11-27 |
4 |
GD |
$0.00 |
$0 |
I/I |
10,360 |
2,590 |
0 |
- |
|
MJN |
Mead Johnson Nutrition Co |
Director |
|
2012-11-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,360 |
5,180 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-11-27 |
4 |
GD |
$0.00 |
$0 |
I/I |
200,630 |
50,158 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-11-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
200,630 |
100,315 |
0 |
- |
|
MJN |
Mead Johnson Nutrition Co |
Director |
|
2013-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,789 |
5,648 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2013-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
46,365 |
135,794 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2013-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,453 |
119,206 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2013-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
12,329 |
260,060 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2013-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
132,390 |
247,731 |
0 |
- |
|
MJN |
Mead Johnson Nutrition Co |
Director |
|
2014-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,876 |
7,524 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Director |
|
2015-02-04 |
4 |
A |
$0.00 |
$0 |
I/I |
31,559 |
31,559 |
0 |
- |
|
133 Records found
|
|
Page 2 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|